Assistant Research Professor at JHU Bloomberg SPH. Former fellow at the Institute for Health Metrics and Evaluation. Everything health policy.
Baltimore, MD
Joined November 2021
- Tweets68
- Following448
- Followers403
- Likes144
In this newly published paper, we find that among beneficiaries with continued mental healthcare utilization, switching from MA to TM was associated with increased mental health visits and a shift in provider composition, suggesting potential care gaps in MA. @Mark_Meiselbach
🚨New publication! 🚨 A new paper from Dr. Angela Liu in the @AJMC_Journal examines the impact of switching from Medicare Advantage to Traditional Medicare on utilization of mental health care.
Read the full article here: ajmc.com/view/mental-health-…
1
97
Come work with me and this team!
🚨 We’re #hiring! @JHU_CHSPM is seeking a DC-based Senior Program Manager to lead projects, manage ops, and support research + policy work.
Apply Now! ➡️ jobs.jhu.edu/job/Washington-…
5
225
Spreading the word -- Department of Health Studies tenure track AP search at the University of Richmond! Dr. Mayes was one of my professors during undergrad and set me on this path down health policy research.
271
Thanks @BSPH_HPM for promoting this important work!
A study led by HPM Assistant Scientist @Angela_HSR investigates a critical issue for Medicare beneficiaries enrolled in Medicare Advantage (MA) plans. The study was published in the @Health_Affairs Scholar journal.
Learn more: publichealth.jhu.edu/2024/st…
13
406
Dropping in to share this preprint article describing Medicare Advantage Trap. High-need beneficiaries in MA may want to switch back to traditional Medicare and purchase Medigap, but face high Medigap premiums, essentially leaving them "trapped" in MA.
academic.oup.com/healthaffai…
We have work in the pipeline focusing on a different patient population, and some primarily data on Medigap premiums across state types. This work was special since it was my first mentoring a grad student...very rewarding
1
100
🚨 New publication alert 🚨
I am so excited to share that I published part of my dissertation work in JAMA HF. A huge thank you to these co-authors: @KellyAnders0n, @jlevy2, @healthecon_dan, and the twitterless Thomas V Johnson and Jerry Anderson
jamanetwork.com/journals/jam…
(2) Using a diff-in-diff framework, we found that step therapy was associated with a 7.8% greater probability of prescribing the plan-preferred drug for the first administration of a treatment episode (predicted probability increased from 0.61 to 0.70).
1
140
In this paper, my team and I leveraged MA encounter data to assess the impact of step therapy on physician-administered drug prescribing, specifically to treat macular degeneration. Humana implemented macular degeneration step therapy, setting Avastin as the plan-preferred drug
150
Angela Liu, PhD
I successfully defended my dissertation earlier this month. A perfect day surrounded by family and friends 🥳
Thrilled to share that I'll be joining Hopkins HPM faculty as an Assistant Scientist. Ready to get to work!
The last 4 years have been fantastic. I've experienced tremendous growth as an independent researcher, thanks in huge part to the incredible mentorship of my advisor, the twitter-less Jerry Anderson, and influential mentors, @healthecon_dan, @jlevy2, @KellyAnders0n, among others
5
405
Interested in Medicare Advantage research topics? @KellyAnders0n led this initiative responding to CMS on how to strengthen RFI data collecting and reporting. Join us in signing!
We've drafted a response to the recent CMS RFI on additional data collection to study the Medicare Advantage program. Want to sign on? Send me an email by Friday March 8th
docs.google.com/document/d/1…
3
617
Congrats to @BSPH_HPM PhD candidate @Ben__Thornburg. Such important work!
🚨NEW RESEARCH🚨 in @JAMA_current : Analysis of U.S. Census Survey data reveals uptick in anxiety and depression among women in states with trigger laws post-Dobbs abortion decision. Led by @JHSPH_CMAP & @BSPH_HPM PhD Candidate @Ben__Thornburg.
6
523
Angela Liu retweeted
Two new papers out in @Health_Affairs and American Journal of Health Economics @ashecon, both concerning self-funded employer-sponsored insurance (ESI).
Self-funded ESI plans are where employers bear the risk (not insurers) and are exempt from state regulations by #ERISA.
Angela Liu retweeted
Check-out the key figure from our recent #JMCP paper led by @Angela_HSR pubmed.ncbi.nlm.nih.gov/3815…
A holiday season publication! We find that infliximab and filgrastim biosimilar uptake from 2017-2019 is consistently higher in MA compared to TM, and that Kaiser HMO plans drive those differences. @dr_msocal @KellyAnders0n, Andrew Xuan, & Jerry Anderson
jmcp.org/doi/full/10.18553/j…
